Venancio Produtos Farmaceuticos Ltda. Sustainability Profile
Venancio Produtos Farmaceuticos Ltda., a prominent player in the pharmaceutical industry, is headquartered in Brazil and operates extensively across various regions within the country. Founded in 1990, the company has established itself as a trusted provider of high-quality pharmaceutical products, focusing on both prescription and over-the-counter medications. With a commitment to innovation, Venancio offers a diverse range of core products, including analgesics, anti-inflammatories, and dermatological treatments, all distinguished by their efficacy and safety. The company’s dedication to research and development has led to significant milestones, positioning it as a leader in the Brazilian market. Venancio Produtos Farmaceuticos Ltda. continues to enhance its reputation through a robust portfolio and a focus on customer satisfaction, making it a key contributor to the healthcare landscape in Brazil.
DitchCarbon Score
How does Venancio Produtos Farmaceuticos Ltda.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Venancio Produtos Farmaceuticos Ltda.'s score of 26 is higher than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Venancio Produtos Farmaceuticos Ltda.'s reported carbon emissions
Venancio Produtos Farmaceuticos Ltda., headquartered in Brazil, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As a result, Venancio's climate commitments and initiatives remain unclear, and there is no information available regarding any emissions reduction strategies or industry benchmarks they may be following. Without emissions data or reduction targets, it is challenging to assess their environmental impact or commitment to sustainability within the pharmaceutical sector.
How Carbon Intensive is Venancio Produtos Farmaceuticos Ltda.'s Industry?
How Carbon Intensive is Venancio Produtos Farmaceuticos Ltda.'s Location?
Venancio Produtos Farmaceuticos Ltda.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Venancio Produtos Farmaceuticos Ltda. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
